208 related articles for article (PubMed ID: 16805684)
1. Comparative analysis of the effects of a novel vacuolar adenosine 5'-triphosphatase inhibitor, FR202126, and doxycycline on bone loss caused by experimental periodontitis in rats.
Niikura K
J Periodontol; 2006 Jul; 77(7):1211-6. PubMed ID: 16805684
[TBL] [Abstract][Full Text] [Related]
2. A novel inhibitor of vacuolar ATPase, FR202126, prevents alveolar bone destruction in experimental periodontitis in rats.
Niikura K; Takeshita N; Chida N
J Toxicol Sci; 2005 Dec; 30(4):297-304. PubMed ID: 16404138
[TBL] [Abstract][Full Text] [Related]
3. Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis.
Niikura K
Cancer Chemother Pharmacol; 2007 Sep; 60(4):555-62. PubMed ID: 17187252
[TBL] [Abstract][Full Text] [Related]
4. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
Niikura K; Takeshita N; Takano M
J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
[TBL] [Abstract][Full Text] [Related]
6. FR177995, a novel vacuolar ATPase inhibitor, exerts not only an inhibitory effect on bone destruction but also anti-immunoinflammatory effects in adjuvant-induced arthritic rats.
Niikura K; Nakajima S; Takano M; Yamazaki H
Bone; 2007 Apr; 40(4):888-94. PubMed ID: 17157574
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats.
Leitão RF; Ribeiro RA; Chaves HV; Rocha FA; Lima V; Brito GA
J Periodontol; 2005 Jun; 76(6):956-63. PubMed ID: 15948691
[TBL] [Abstract][Full Text] [Related]
9. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
Niikura K; Takano M; Sawada M
Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
[TBL] [Abstract][Full Text] [Related]
10. A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
Llavaneras A; Ramamurthy NS; Heikkilä P; Teronen O; Salo T; Rifkin BR; Ryan ME; Golub LM; Sorsa T
J Periodontol; 2001 Aug; 72(8):1069-77. PubMed ID: 11525440
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats.
Lima V; Vidal FD; Rocha FA; Brito GA; Ribeiro RA
J Periodontol; 2004 Jan; 75(1):162-8. PubMed ID: 15025228
[TBL] [Abstract][Full Text] [Related]
12. Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats.
Verzeletti GN; Gaio EJ; Rösing CK
Acta Odontol Scand; 2007 Nov; 65(6):348-51. PubMed ID: 18071956
[TBL] [Abstract][Full Text] [Related]
13. Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats.
Menezes AM; Rocha FA; Chaves HV; Carvalho CB; Ribeiro RA; Brito GA
J Periodontol; 2005 Nov; 76(11):1901-9. PubMed ID: 16274309
[TBL] [Abstract][Full Text] [Related]
14. Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis.
Mitsuta T; Horiuchi H; Shinoda H
J Periodontol; 2002 May; 73(5):479-86. PubMed ID: 12027248
[TBL] [Abstract][Full Text] [Related]
15. Low-dose doxycycline prevents inflammatory bone resorption in rats.
Bezerra MM; Brito GA; Ribeiro RA; Rocha FA
Braz J Med Biol Res; 2002 May; 35(5):613-6. PubMed ID: 12011948
[TBL] [Abstract][Full Text] [Related]
16. Effect of low-dose doxycycline on serum oxidative status, gingival antioxidant levels, and alveolar bone loss in experimental periodontitis in rats.
Yağan A; Kesim S; Liman N
J Periodontol; 2014 Mar; 85(3):478-89. PubMed ID: 23786405
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone administration may modulate periodontal tissue levels of interleukin-6, matrix metalloproteinase-2 and matrix metalloproteinase-9 in experimental periodontitis.
Marques MR; dos Santos MC; da Silva AF; Nociti FH; Barros SP
J Periodontal Res; 2009 Dec; 44(6):744-50. PubMed ID: 19453852
[TBL] [Abstract][Full Text] [Related]
18. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption.
Qin A; Cheng TS; Pavlos NJ; Lin Z; Dai KR; Zheng MH
Int J Biochem Cell Biol; 2012 Sep; 44(9):1422-35. PubMed ID: 22652318
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats.
Buduneli E; Vardar S; Buduneli N; Berdeli AH; Türkoğlu O; Başkesen A; Atilla G
J Periodontol; 2004 Nov; 75(11):1516-23. PubMed ID: 15633329
[TBL] [Abstract][Full Text] [Related]
20. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
Lee HM; Ciancio SG; Tüter G; Ryan ME; Komaroff E; Golub LM
J Periodontol; 2004 Mar; 75(3):453-63. PubMed ID: 15088884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
